We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tests for POC and Homeland Defense

By HospiMedica staff writers
Posted on 10 Dec 2003
Exclusive rights to market an innovative line of rapid-result blood and urine tests have been granted to QT 5, Inc. More...
(Westlake Village, CA, USA; www.qt5inc.com) by an undisclosed source. The diagnostic platform was specifically designed for point-of-care (POC) and ambulatory use as well as for the emerging homeland defense market.

The patented test platform incorporates a combination of a solid phase membrane and immunologic-based reagents in a single-use disposable test device. The platform has the capacity for providing rapid POC testing for a wide variety of medical conditions. The diagnostic platform is highly flexible and capable of testing for important infectious diseases, drugs, and drug metabolites. Depending upon the application, this platform technology may provide either quantitative or qualitative test results in minutes with a high degree of accuracy.

QT 5 will include in its initial product offering a low-cost, small-footprint desktop analyzer designed for use with the rapid test cartridges. A handheld mobile version of the multiple assay analyzer will be compatible with a wide variety of new tests being developed for use by paramedics, assisted-living facilities, and military groups. QT 5 has developed another line of qualitative fast tests for rubella, herpes virus, rotavirus, strep group A, and infectious mononucleosis that have been cleared by the U.S. Food and Drug Administration (FDA).




Related Links:
QT 5

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
HPV Test
Allplex HPV28 Detection
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.